Clinical Chart Review: Traditional vs RAAPID.AI

In a recent study by MarketsandMarkets conducted to understand the advantages of artificial intelligence (AI) in the healthcare market, AI is estimated to reach $67.4 billion by 2027. ¹

Have you adopted an AI-Enabled Risk Adjustment solution for your medical chart reviews?
Are you still dependent on multiple codebooks and performing a time-consuming manual chart review workflow?

This infographic with comparative analysis will highlight key areas of a medical chart review and how AI is helping the transformation to Value-Based Care.

Infographics Clinical Chart Review Traditional vs RAAPID 1

 

Ref:

¹https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

Share:

Lastest Post

Subscribe To Our Newsletter

Disclaimer: All the information, views, and opinions expressed in this blog are those of the authors and their respective web sources and in no way reflect the principles, views, or objectives of RAAPID.